Cargando…
BET 1: The role of remdesivir in COVID-19 infection
A short-cut review of the available medical literature was carried out to establish whether remdesivir was an effective treatment for patients with confirmed COVID-19 infection. After abstract review, five papers were found to answer this clinical question using the detailed search strategy. The aut...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418609/ https://www.ncbi.nlm.nih.gov/pubmed/32753375 http://dx.doi.org/10.1136/emermed-2020-210336.02 |
_version_ | 1783569722876362752 |
---|---|
author | Baombe, Janos P |
author_facet | Baombe, Janos P |
author_sort | Baombe, Janos P |
collection | PubMed |
description | A short-cut review of the available medical literature was carried out to establish whether remdesivir was an effective treatment for patients with confirmed COVID-19 infection. After abstract review, five papers were found to answer this clinical question using the detailed search strategy. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. It is concluded that despite some recent promising studies, further well-designed and larger trials are needed to answer this specific question. |
format | Online Article Text |
id | pubmed-7418609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-74186092020-08-18 BET 1: The role of remdesivir in COVID-19 infection Baombe, Janos P Emerg Med J Best Evidence Topic reports A short-cut review of the available medical literature was carried out to establish whether remdesivir was an effective treatment for patients with confirmed COVID-19 infection. After abstract review, five papers were found to answer this clinical question using the detailed search strategy. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. It is concluded that despite some recent promising studies, further well-designed and larger trials are needed to answer this specific question. BMJ Publishing Group 2020-08 2020-07-23 /pmc/articles/PMC7418609/ /pubmed/32753375 http://dx.doi.org/10.1136/emermed-2020-210336.02 Text en © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Best Evidence Topic reports Baombe, Janos P BET 1: The role of remdesivir in COVID-19 infection |
title | BET 1: The role of remdesivir in COVID-19 infection |
title_full | BET 1: The role of remdesivir in COVID-19 infection |
title_fullStr | BET 1: The role of remdesivir in COVID-19 infection |
title_full_unstemmed | BET 1: The role of remdesivir in COVID-19 infection |
title_short | BET 1: The role of remdesivir in COVID-19 infection |
title_sort | bet 1: the role of remdesivir in covid-19 infection |
topic | Best Evidence Topic reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418609/ https://www.ncbi.nlm.nih.gov/pubmed/32753375 http://dx.doi.org/10.1136/emermed-2020-210336.02 |
work_keys_str_mv | AT baombejanosp bet1theroleofremdesivirincovid19infection |